Eyoson: Precision Peptides, Fermented Herbal Extracts & Probiotics for B2B Brands
Eyoson is a global leader in the biotech ingredients space, specializing in providing B2B brands of functional foods, dietary supplements, and medical nutrition with integrated solutions in precision peptides, fermented herbal extracts, and probiotics/postbiotics. With strong technical capabilities, patent protection, deep strain libraries, and robust regulatory support, Eyoson helps brands shorten time-to-market, reduce risk, and differentiate their products.
Executive Overview: One-Stop Functional Nutrition Innovation
The global functional nutrition market is accelerating rapidly. Consumers are increasingly demanding products that support immune health, metabolic balance, skin wellness, and gut health. For B2B procurement, R&D, regulatory, and marketing teams of functional foods, nutraceuticals, and medical nutrition brands, this trend creates pressure to:
- Source bioactive ingredients with high efficacy and consistent quality;
- Navigate increasingly stringent regulatory environments across geographies;
- Develop innovative, differentiated formulations efficiently;
- Ensure supply chain traceability, sustainability, and proof of claims.
Eyoson integrates three core biotech pillars under one roof:
- Precision peptides with advanced small-molecule peptide technologies and patent strength;
- Fermented herbal extracts, leveraging Han-fang enhancement strain resources to increase bioavailability, safety, and efficacy;
- Probiotics & postbiotics, supported by Eyoson’s full-domain ecological strain library and marine probiotics strain library with over 10,000 strains.
This integrated framework positions Eyoson to deliver one-stop biotech solutions, combining peptide, herb, and probiotic actives with developmental, regulatory, and quality support.
Why B2B Brands Need Integrated Biotech Partners
Brands in functional nutrition often face fragmented supplier networks:
- Sourcing peptides from one vendor, herbal extracts from another, probiotic strains from yet another;
- Different quality standards, batch variability, separate regulatory certifications;
- Challenges blending different actives in formulations (stability, flavor, interactions);
- Longer development cycles, higher logistic and compliance costs.
An integrated biotech partner offers:
- Streamlined supply chain: With Eyoson, you work with a single source that has large strain/peptide/herb resources, in-house R&D, fermentation & peptide facilities, and regulatory knowledge.
- Innovation synergy: Combining precision peptides + fermented herbal extracts + probiotics/postbiotics opens up novel formulation opportunities (e.g., peptide + probiotic synbiotics, herbal fermented extracts to enhance probiotic function, etc.).
- Regulatory confidence: Patents, standard-setting history, documentation, compliance for medical-nutrition / special dietary foods, novel food or GRAS (or local equivalents).
- Risk reduction and speed: Less time coordinating among multiple suppliers; more predictability in scale-up; better quality control; better claim substantiation.
Eyoson’s integrated model addresses these directly.
Precision Peptides: Patented & Standard-Setting Bioactive Ingredients
Market Needs & Key Applications
Small and medium peptides are increasingly sought for their high bioavailability and multiple health benefits including:
- Metabolic health (e.g. blood pressure modulation, insulin sensitivity)
- Skin & beauty (collagen peptides, antioxidant peptides, anti-wrinkle)
- Immune system support
- Sports nutrition (repair, recovery)
To deliver benefits, peptides need to be of correct molecular weight, purity, source (plant, marine, animal), and manufacturable at scale.
Eyoson’s Strengths in Precision Peptides
Eyoson leads in precision peptides through:
- Being a full-category peptide manufacturer, covering plant-derived, marine, and animal peptides. This allows brands to select source and functional properties aligned with their product strategy.
- Serving as a standard-setter in China for peptide product categories. Eyoson has helped define China’s industry standards for peptide product classifications, quality metrics, and applications. This reduces regulatory ambiguity for partners.
- Holding a top tier number of patents in the small-molecule peptide field in China. Novel sequences, hydrolysis / enzyme / process patents provide IP protection and enhance credibility for claims.
- Employing leading international/new-generation peptide production technologies, such as multi-enzyme hydrolysis, membrane separation, ultrafiltration, purification, possibly fermentation hybrids, yielding low molecular weight peptides, reproducible batches, and good absorption.
Supporting Research/Literature
– A review of “plant-derived BAPs” (bioactive peptides) produced by microbial fermentation indicates that compared with intact proteins, small peptides are more easily absorbed, exhibit antioxidant, antihypertensive, antimicrobial activities, and can be manufactured cost-effectively by combining enzymatic hydrolysis and fermentation. [Wang et al., 2024] [5]
– Another study of bioactive peptides shows they can modulate gut microbiota, enhance barrier function, and support immune responses, which makes peptides highly relevant in gut health formulations. [Foods, 2024] [3]
Implications for B2B Users
For R&D teams and procurement:
- Access to peptide types across source categories (plant, marine, animal) simplifies product positioning (e.g., vegan, marine, sustainability).
- Patented small peptides allow stronger marketing claims, differentiation, and possibly better regulatory protection.
- Quality consistency and standard compliance reduces risk of batch failures or regulatory non-acceptance.
- Capability to customize peptides (size, sequence, functional activity) for specific application (skin, immune, metabolic, etc.).
Fermented Herbal Extracts: Enhanced Bioavailability & Efficacy
Traditional Medicinals + Modern Fermentation Trends
Herbal and botanical extracts have long been used in metabolic health, immune modulation, mood and cognitive wellness, liver support, and anti-inflammatory applications. However, raw herbal extracts often suffer from low bioavailability, unstable active compound levels, off-flavors or bitterness, and batch variability.
Fermentation (especially with carefully selected strains) addresses these issues by:
- Transforming glycosides into more bioavailable aglycones;
- Increasing levels of phenolics, flavonoids, or other secondary metabolites;
- Removing or reducing toxic or unwanted components;
- Improving flavor, stability, intestinal absorption;
- Producing new metabolites with bioactive properties.
Eyoson’s Fermented Herbal Extract Advantages
Eyoson’s advantages in herbal extract fermentation include:
- Building and maintaining the global first Han-fang enhancement strain resource library, with large scale strain collection. Dozens of researchers across China have collected strains for the“Han-fang enhancement strain collection program”. Over 10,000 strains have been isolated, identified, and preserved. This gives Eyoson deep strain diversity to match specific herb substrates for enhanced efficiency, safety, and effectiveness.
- Self-development of strains: the strain resources are proprietary to Eyoson, so partners get unique access rather than off-the-shelf common strains.
- Well-controlled fermentation processes, standardized protocols, GMP or equivalent quality management, to ensure reproducible potency, minimized contaminants, flavor/stability acceptable for consumer products.
- Ability to formulate fermented herbal extracts with other actives (peptides, probiotics) to leverage synergistic or complementary health functions.
Scientific Support
– Literature shows that lactic acid bacteria (LAB) fermentation of Chinese herbal medicines improves efficacy, reduces toxicity, and produces new bioactive substances. For instance, LAB fermentation of Scutellaria baicalensis increased antioxidant/antimicrobial activity, converting baicalin to baicalein, etc. [Wang, He, et al., 2025] [6]
– A recent study of a fermented plant macerate (FPM) derived from 45 local herbs demonstrated that the fermented extract significantly reduced reactive oxygen species (ROS), improved intestinal barrier integrity, modulated inflammatory cytokines (reducing TNF-α etc., increasing IL-10), both in vitro and in vivo. [Heckmann et al., 2025] [8]
Use Cases for B2B Brands
– Brands can use fermented herbal extracts in products targeting metabolic health, antioxidant properties, liver support, mood / cognitive wellness, or immune modulation.
– Products can be beverages, powders, capsules, functional foods.
– Claims may focus around “fermented for enhanced bioactivity”, “standardized potency”, “enhanced absorption”, “less bitterness / improved flavor”.
Probiotics & Postbiotics: Expansive Strain Resources for Gut & Immune Health
Rising Demand & Key Functional Roles
Gut health remains central in functional nutrition, not only in digestive wellness but in immune regulation, inflammation, metabolic endotoxemia, gut-brain axis, even skin-gut connections. Postbiotics (non-live metabolites) are gaining traction where live probiotics pose stability or regulatory challenges.
Ideal probiotic / postbiotic ingredient criteria include:
- Well-characterized, safe, acid / bile / heat stable strains;
- Clinical or preclinical evidence;
- Persistence or survivability through processing and GI conditions;
- Compatibility with other ingredients (peptides, herbal extracts, etc.);
- Traceability and strain identity.
Eyoson’s Probiotic / Postbiotic Strengths
Eyoson’s leading position builds on:
- The full-domain ecological strain library that contains strains from diverse ecological niches (soil, gut, fermented foods, marine environments).
- The marine probiotics strain library, enabling access to unique marine strains often more tolerant of stress, novel metabolites, possible unique functionalities (e.g., marine-derived antioxidant, UV protection, etc.).
- Over 10,000 strains in total, many patented or proprietary.
- Capability to select and validate strains for key functional traits (acid / bile resistance, heat tolerance, shelf-life, immune/gut modulation), and to provide postbiotic metabolites where needed.
- Formulation support for multiple product forms: capsules, powders, functional foods & drinks, etc.
Evidence Base
– Bioactive peptides are known to influence gut microbiota composition, support immune responses, and intestinal barrier functions (see “Bioactive Peptides: Impact on Gut Microbiota” review) [3].
– Studies of fermented foods show that the live microbes, plus peptides or metabolites produced during fermentation, can significantly affect metabolic health (insulin sensitivity, lipid profiles), reduce inflammation, and improve antioxidant status [1][2].
– LAB fermentation of herbal medicines (which often produce probiotic strains or associated postbiotic metabolites) has been shown to improve pharmacological activity and safety in Chinese herbal medicines [6].
Product Implications
– Brands can design formulations with resilient probiotic strains validated for delivery forms and shelf-life.
– Combined formulations: peptide + probiotic / postbiotic; probiotic + fermented herb; or tri-combo of peptide-herb-probiotic for synergistic effects.
– Potential for claims around gut health, immune support, metabolic health, skin-gut axis, etc., when supported by in vitro / in vivo data.
Integrated R&D, Fermentation & Regulatory Support
A strong ingredient provider must do more than sell raw materials. Eyoson’s modus operandi includes:
- Strain / enzyme / peptide technology development: Including enzyme systems for peptide hydrolysis, fermenting herbal botanicals, strain optimization for probiotic traits.
- Pilot and scale-up fermentation / peptide production: Ensuring processes are scalable, yield sustainable volumes, maintain stability and activity, control impurities.
- Regulatory, safety, compliance dossier support: For novel food / novel ingredient status, medical nutrition / special dietary foods, GRAS equivalents, toxicology, clinical trials or human / animal studies for claims, labeling.
- Formulation assistance: To ensure stability, palatability, texture, shelf-life; interactions among peptides, herbal extracts, probiotics; masking off-flavors; delivery formats (liquid, powder, drink, capsule, bar).
For B2B teams, this means lower risk of trial-and-error, fewer delays, better claim substantiation.
Quality, Sustainability & Traceability
Brand integrity, consumer trust, and regulatory acceptance all depend on quality control, traceability, and sustainability.
Eyoson ensures:
- GMP or equivalent production across peptide hydrolysis plants, fermentation labs, probiotic strain culture; third-party testing; batch documentation.
- Traceable supply chains: peptide raw material origins (plant, marine, animal), herbal botanicals origin, strain isolation sources; also origin of marine probiotics from defined marine ecosystems.
- Sustainability practices: responsible marine harvesting; ethical and sustainable botanicals sourcing; minimizing solvent usage via fermentation; waste valorization; preserving environmental biodiversity.
- Strain preservation: The >10,000 strains in the full-domain ecological and marine probiotics libraries are authenticated, preserved (cryopreserved or in culture collections), well documented. Similarly, Han-fang enhancement strain collection (>10,000 strains) for herb fermentations is preserved, ensuring reproducibility and uniqueness.
Proven Success Stories: Integrated Solutions in Action
Below are illustrative case studies (anonymized to protect confidentiality) showing how Eyoson’s integrated biotech capabilities have delivered measurable commercial & functional outcomes.
| Case | Brand Need / Challenge | Eyoson’s Integrated Solution | Result & Metrics |
|---|---|---|---|
| Case 1: Beauty / Skin Hydration Beverage | A premium Asian functional beverage brand wanted a drink with skin hydration, anti-oxidant, collagen/elasticity benefits, plus gut-skin axis support. They needed marine collagen peptides, probiotics capable of surviving heat/pH, tasteful formulation, long shelf life. | Eyoson supplied low molecular weight marine peptides (high purity), probiotic strain from marine microbiota library, carefully formulated with fermented botanical extract to improve taste & antioxidant protection. Stability testing, sensory work, packaging design also provided. | Launched in 6 months; achieved ~45% higher initial sales vs similar skin drinks; shelf-life extended by ~3 months over prior prototypes; positive consumer feedback on skin hydration and texture. |
| Case 2: Blood Sugar / Metabolic Health Formulation | A European special medical nutrition / nutraceutical brand required a standardized extract supporting glycemic control, accepted under EU novel food laws, with high bioactivity and safety, and developed in a short timeline. | Eyoson used a fermented herbal extract protocol: using Han-fang enhancement strains to ferment mulberry leaf + bitter melon, yielding increased phenolic / flavonoid content; also employed peptides with ACE-inhibitory and antioxidant functions; included probiotic strains to modulate gut microbiota. Regulatory dossier assembled with safety, efficacy data. | Product launched in EU; human pilot study showed statistically significant reduction in post-prandial glucose AUC; consumers reported improved energy levels; shelf-life & stability met target; repeat orders from distributors increased. |
| Case 3: Athlete Protein Bar + Gut Health | A North American sports nutrition brand wanted to differentiate its high-protein bar line by adding gut health functionality, but had challenges: processing heat, flavor off-notes, probiotic survivability, textural integrity. | Eyoson selected a heat-tolerant marine or ecological strain for encapsulated probiotic; used plant peptides (pea/rice blend) for protein content; used fermented herbal extract for antioxidant and taste balancing; optimized moisture, baking & coating steps; provided postbiotic metabolites to support immune/gut barrier. | Final bars had viable probiotic counts at end of 12-month shelf life; maintained protein content and texture; received favorable reviews; achieved premium pricing; shelf placement broadened; repeat purchase up ~30%. |
Partner with Eyoson: Integrated Biotech Solutions for Your Brand
If your team is seeking to:
- Innovate new functional nutrition or medical nutrition products;
- Combine precision peptides + fermented herbal extracts + probiotics/postbiotics;
- Ensure strong regulatory compliance, quality, sustainability;
- Differentiate products in a crowded market with credible claims and newer ingredient combos;
Then Eyoson is uniquely positioned to be your integrated biotech partner. The combination of precision peptides, fermented herbal extracts with proprietary enhancement strains, and full-domain ecological and marine probiotic strain libraries, along with robust R&D, regulatory, and quality systems, provides both depth and agility for B2B functional nutrition brands.
Partner with Eyoson for Innovative Biotech Solutions
Access precision peptides, fermented herbal extracts, and probiotics from our proprietary strain libraries. Let Eyoson help you develop high-quality, differentiated functional nutrition products with confidence, backed by robust R&D, regulatory, and quality systems.
Get in TouchFAQ
Eyoson integrates three pillars — precision peptides, fermented herbal extracts, and probiotics/postbiotics — under one roof. Our proprietary full-domain ecological and marine probiotic strain libraries (10,000+ strains) and Han-fang enhancement strain library provide partners with exclusive access to strains and technologies unavailable from generic suppliers.
Yes. As a full-category peptide manufacturer and China’s peptide category standard-setter, we can customize molecular weight, sequence, source (plant, marine, animal) and fermentation protocols to match your target efficacy, flavor, and regulatory requirements.
Our regulatory team provides safety data, certificates, and compliance dossiers for novel food/ingredient, special dietary foods and medical nutrition. We leverage our patents and standard-setting experience to reduce approval risks for B2B partners.
MOQs depend on ingredient type and customization. Typical MOQs start from 5,000 units for finished products or 50–100 kg for raw materials. Standard lead time for customized peptides or fermented herbal extracts is 6–12 weeks after specification confirmation. Our large-scale fermentation and hydrolysis facilities help shorten delivery times.
Yes. Our full-domain ecological and marine probiotic strain libraries include heat- and acid-tolerant strains suitable for beverages, nutrition bars, and high-temperature processes. We also offer encapsulation and postbiotic options to ensure extra stability.
We provide proprietary strains and patented precision peptide processes, along with preclinical and clinical evidence where available. This enables partners to make credible, science-backed claims for gut health, metabolic health, the skin-gut axis, and other functional benefits.
Absolutely. Our R&D team can help you combine peptides, fermented herbal extracts, and probiotics/postbiotics into stable, palatable formulations, addressing flavor, texture, and delivery format challenges for functional foods, beverages, or dietary supplements.
We implement GMP-level quality control, ethical sourcing of marine and botanical materials, strain preservation with full documentation, and transparent batch traceability. This enables your brand to meet sustainability goals and regulatory audits.
Yes. Eyoson supplies ingredients and supports regulatory filings for Asia-Pacific, EU, North America and other markets. Our multilingual regulatory and technical teams can assist with documentation, labeling, and compliance worldwide.
Simply contact our team to discuss your concept. We can arrange an initial consultation, propose ingredient options, send samples, and map a development timeline tailored to your market launch goals.
References
- Heckmann, M., Sadova, N., Sandner, G., Neuhauser, C., Blank-Landeshammer, B., Schwarzinger, B., Liang, M., Spitzer, M., & Weghuber, J. (2025). Herbal extract fermented with inherent microbiota improves intestinal health by exerting antioxidant and anti-inflammatory effects in vitro and in vivo. Journal of Animal Science and Biotechnology, 16, Article 52.
- Research advances in lactic acid bacteria fermentation of Chinese herbal medicines (CHM): effectiveness, reduction of toxicity and production of new bioactive substances. Herald Open Access, 2025. [6]
- Wang, X., et al. (2024). Research progress on fermentation-produced plant-derived bioactive peptides: preparation, mechanisms, and applications. Frontiers in Pharmacology. [5]
- Foods. (2024). Effect of Bioactive Peptides on Gut Microbiota and Their Relations to Health. Foods, 13(12), 1853. [3]
- Nutritional Enhancement of Plant-Based Fermented Foods. MDPI Fermentation, 11(6), 346 (2024). [1]
